The NIH Office of Laboratory Animal Welfare (OLAW) is seeking public input on flexibilities that IACUCs may consider when conducting semiannual program reviews as a...
Read The Article“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...
Read The ArticleThe FDA has released a draft guidance document, “Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft...
Read The ArticleThe FDA has published the guidance document, “E8(R1) General Considerations for Clinical Studies,” to assist those that design clinical studies by outlining the internationally accepted...
Read The ArticleThe U.S. Food and Drug Administration (FDA) has resumed its unannounced foreign inspections program in India, yet it remains paused in China due to COVID-19...
Read The Article“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...
Read The ArticleCITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for...
Read The ArticleThe Office for Human Research Protections (OHRP) recently released the guidance, “General Instructions on the Informed Consent Posting Requirement (45 CFR 46.116(h)).” The first of...
Read The ArticleThe U.S. National Library of Medicine has updated the Clinicaltrials.gov FAQs to address expanded access and all-cause mortality. The expanded access FAQs cover: What is...
Read The ArticleThe Office for Civil Rights (OCR) at the United States Department of Health and Human Services is seeking public input on recognized security practices as...
Read The Article
